AVEANNA HEALTHCARE HOLDINGS (AVAH) Stock Fundamental Analysis
NASDAQ:AVAH - Nasdaq - US05356F1057 - Common Stock - Currency: USD
Taking everything into account, AVAH scores 3 out of 10 in our fundamental rating. AVAH was compared to 105 industry peers in the Health Care Providers & Services industry. AVAH has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, AVAH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year AVAH was profitable.
AVAH had a positive operating cash flow in the past year.
In the past 5 years AVAH always reported negative net income.
In multiple years AVAH reported negative operating cash flow during the last 5 years.
1.2 Ratios
AVAH has a Return On Assets (-0.66%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 8.81%, AVAH is doing good in the industry, outperforming 80.00% of the companies in the same industry.
AVAH had an Average Return On Invested Capital over the past 3 years of 5.94%. This is below the industry average of 8.81%.
The last Return On Invested Capital (8.81%) for AVAH is above the 3 year average (5.94%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.66% | ||
| ROE | N/A | ||
| ROIC | 8.81% |
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
1.3 Margins
With a decent Operating Margin value of 6.98%, AVAH is doing good in the industry, outperforming 73.33% of the companies in the same industry.
AVAH's Operating Margin has improved in the last couple of years.
The Gross Margin of AVAH (31.39%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AVAH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.98% | ||
| PM (TTM) | N/A | ||
| GM | 31.39% |
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
2. Health
2.1 Basic Checks
AVAH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AVAH has more shares outstanding than it did 1 year ago.
AVAH has more shares outstanding than it did 5 years ago.
AVAH has a better debt/assets ratio than last year.
2.2 Solvency
AVAH has an Altman-Z score of 0.62. This is a bad value and indicates that AVAH is not financially healthy and even has some risk of bankruptcy.
AVAH has a Altman-Z score of 0.62. This is in the lower half of the industry: AVAH underperforms 74.29% of its industry peers.
AVAH has a debt to FCF ratio of 55.28. This is a negative value and a sign of low solvency as AVAH would need 55.28 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 55.28, AVAH is in line with its industry, outperforming 46.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 55.28 | ||
| Altman-Z | 0.62 |
ROIC/WACC0.88
WACC10.04%
2.3 Liquidity
A Current Ratio of 0.98 indicates that AVAH may have some problems paying its short term obligations.
AVAH has a worse Current ratio (0.98) than 76.19% of its industry peers.
AVAH has a Quick Ratio of 0.98. This is a bad value and indicates that AVAH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AVAH (0.98) is worse than 68.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 141.67% over the past year.
Measured over the past years, AVAH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -49.58% on average per year.
AVAH shows a small growth in Revenue. In the last year, the Revenue has grown by 6.83%.
The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)141.67%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%350%
Revenue 1Y (TTM)6.83%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%8.57%
3.2 Future
Based on estimates for the next years, AVAH will show a very strong growth in Earnings Per Share. The EPS will grow by 80.86% on average per year.
The Revenue is expected to grow by 5.25% on average over the next years.
EPS Next Y144.8%
EPS Next 2Y92.38%
EPS Next 3Y80.86%
EPS Next 5YN/A
Revenue Next Year5.63%
Revenue Next 2Y5.31%
Revenue Next 3Y5.25%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 91.60 indicates a quite expensive valuation of AVAH.
AVAH's Price/Earnings ratio is in line with the industry average.
AVAH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.64.
AVAH is valuated quite expensively with a Price/Forward Earnings ratio of 37.42.
AVAH's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.44, AVAH is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 91.6 | ||
| Fwd PE | 37.42 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AVAH is on the same level as its industry peers.
AVAH's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.95 | ||
| EV/EBITDA | 13.16 |
4.3 Compensation for Growth
AVAH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AVAH's earnings are expected to grow with 80.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.63
PEG (5Y)N/A
EPS Next 2Y92.38%
EPS Next 3Y80.86%
5. Dividend
5.1 Amount
AVAH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:AVAH (4/24/2025, 11:53:58 AM)
4.58
+0.09 (+2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.67%
Inst Owner Change-0.01%
Ins Owners5.91%
Ins Owner Change5.97%
Market Cap893.51M
Analysts50.77
Price Target5.84 (27.51%)
Short Float %1.52%
Short Ratio5.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1158.82%
Min EPS beat(2)256.86%
Max EPS beat(2)2060.78%
EPS beat(4)4
Avg EPS beat(4)626.19%
Min EPS beat(4)38.08%
Max EPS beat(4)2060.78%
EPS beat(8)7
Avg EPS beat(8)322.25%
EPS beat(12)7
Avg EPS beat(12)186.01%
EPS beat(16)8
Avg EPS beat(16)138.55%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.61%
Max Revenue beat(2)2.02%
Revenue beat(4)3
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)2.02%
Revenue beat(8)7
Avg Revenue beat(8)1.05%
Revenue beat(12)8
Avg Revenue beat(12)0.06%
Revenue beat(16)8
Avg Revenue beat(16)-0.98%
PT rev (1m)1.91%
PT rev (3m)6.37%
EPS NQ rev (1m)-142.94%
EPS NQ rev (3m)N/A
EPS NY rev (1m)57.38%
EPS NY rev (3m)52.73%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0.51%
Revenue NY rev (3m)0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 91.6 | ||
| Fwd PE | 37.42 | ||
| P/S | 0.44 | ||
| P/FCF | 33.95 | ||
| P/OCF | 27.38 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.16 |
EPS(TTM)0.05
EY1.09%
EPS(NY)0.12
Fwd EY2.67%
FCF(TTM)0.13
FCFY2.95%
OCF(TTM)0.17
OCFY3.65%
SpS10.38
BVpS-0.63
TBVpS-6.49
PEG (NY)0.63
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.66% | ||
| ROE | N/A | ||
| ROCE | 11.2% | ||
| ROIC | 8.81% | ||
| ROICexc | 9.44% | ||
| ROICexgc | 293.92% | ||
| OM | 6.98% | ||
| PM (TTM) | N/A | ||
| GM | 31.39% | ||
| FCFM | 1.3% |
ROA(3y)-15.89%
ROA(5y)-11.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.94%
ROIC(5y)5.12%
ROICexc(3y)6.24%
ROICexc(5y)5.39%
ROICexgc(3y)148.4%
ROICexgc(5y)163.95%
ROCE(3y)7.54%
ROCE(5y)6.51%
ROICexcg growth 3Y3.46%
ROICexcg growth 5Y50.58%
ROICexc growth 3Y35.54%
ROICexc growth 5Y22.27%
OM growth 3Y7.46%
OM growth 5Y9.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y0.71%
F-Score6
Asset Turnover1.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 55.28 | ||
| Debt/EBITDA | 7.5 | ||
| Cap/Depr | 21.74% | ||
| Cap/Sales | 0.31% | ||
| Interest Coverage | 0.93 | ||
| Cash Conversion | 19.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.62 |
F-Score6
WACC10.04%
ROIC/WACC0.88
Cap/Depr(3y)32.8%
Cap/Depr(5y)53.1%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.67%
EPS 3Y-49.58%
EPS 5YN/A
EPS Q2Q%350%
EPS Next Y144.8%
EPS Next 2Y92.38%
EPS Next 3Y80.86%
EPS Next 5YN/A
Revenue 1Y (TTM)6.83%
Revenue growth 3Y6.44%
Revenue growth 5Y7.9%
Sales Q2Q%8.57%
Revenue Next Year5.63%
Revenue Next 2Y5.31%
Revenue Next 3Y5.25%
Revenue Next 5YN/A
EBIT growth 1Y24.26%
EBIT growth 3Y14.38%
EBIT growth 5Y18.06%
EBIT Next Year29.86%
EBIT Next 3Y14.56%
EBIT Next 5YN/A
FCF growth 1Y58.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.95%
OCF growth 3YN/A
OCF growth 5YN/A